Versor Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,200
Closed -$318K 788
2025
Q3
$318K Buy
+26,200
New +$355K 0.06% 470
2025
Q2
Sell
-30,500
Closed -$584K 935
2025
Q1
$584K Buy
+30,500
New +$893K 0.1% 359
2024
Q3
Sell
-6,800
Closed -$274K 978
2024
Q2
$274K Buy
+6,800
New +$284K 0.05% 550
2023
Q2
Sell
-9,457
Closed -$384K 836
2023
Q1
$384K Sell
9,457
-2,145
-18% -$88.8K 0.05% 413
2022
Q4
$522K Sell
11,602
-3,000
-21% -$136K 0.04% 336
2022
Q3
$699K Sell
14,602
-2,461
-14% -$135K 0.04% 338
2022
Q2
$1.01M Buy
17,063
+13,363
+361% +$1.1M 0.04% 248
2022
Q1
$430K Buy
3,700
+2,285
+161% +$267K 0.02% 373
2021
Q4
$213K Buy
+1,415
New +$191K 0.01% 487
2019
Q3
Sell
-20,500
Closed -$1.32M 340
2019
Q2
$1.32M Buy
20,500
+11,300
+123% +$729K 0.09% 125
2019
Q1
$584K Sell
9,200
-4,100
-31% -$215K 0.06% 161
2018
Q4
$505K Buy
+13,300
New +$470K 0.12% 162

Other funds holding TNDM

Versor Investments's TNDM Position: Q4 2025 in Review

Versor Investments sold out of Tandem Diabetes Care (TNDM) in Q4 2025, closing a stake of 26,200 shares — an estimated $318K sold.

Versor Investments first reported a position in TNDM in Q4 2018 and held it in 12 quarters. The position peaked at $1.32M in Q2 2019. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2025.

  • Versor Investments reported no remaining Tandem Diabetes Care position as of Q4 2025 after selling out during the quarter.
  • Versor Investments sold 26,200 Tandem Diabetes Care shares in Q4 2025, an estimated $318K.
  • Versor Investments first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 12 quarters.
  • Versor Investments's Tandem Diabetes Care position peaked at $1.32M in Q2 2019.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2025.

Based on Versor Investments's 13F filing for Q4 2025, filed 4 Feb 2026.